The spring issue of "New You" magazine features "The Stem Cell Revolution". Cell Therapy Foundation's Chief Medical Advisor Keith March and Executive Director Raquel Ravinet were interviewed for this article. You can check out the full article "The Stem Cell Revolution" on New You Magazine. We've also included a short excerpt below.
Keith March, MD, PhD, is a professor at the Indiana University School of Medicine who also chairs the Data Safety and Monitoring Board for stem cell research at the National Institutes of Health (NIH). While he is quick to point out that he “can’t speak for the whole of the NIH,” March says that so far the trials are showing some amazing results. “The type of stem cell found in bone marrow and fat… has a tendency to form bone, fat, muscle, cartilage and blood vessels,” he says. In terms of specific trials, “It does appear that the adipose derived stem cells can substantially limit the amount of damage from a heart attack.”
March is currently monitoring clinical trials on all sorts of fat-derived stem cell trials, from curing emphysema and cerebral palsy, to diabetes and Crohn’s disease. The problem, he says, is that most of these trials are being conducted outside of the U.S. “The FDA approach is a very cautious approach,” he says.
“There are different schools of thought about how quickly new technologies and new procedures should be brought to the general public,” says Raquel Ravinet, executive director of the Cell Therapy Foundation, a non-profit that raises funds for adult stem cell research. “With something that looks to change the medical game as quickly as stem cells, you have people who say, ‘It’s a new day, lets start now.’ Others say, ‘Let’s slow down, we’ve heard this before, let’s do more study on this.’